Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Ciba Vision introduces ocular formulation of lomefloxacin in U.K.

Nov. 15, 1999

Visudyne submitted for marketing approval in Canada

Nov. 8, 1999

Mycophenolate mofetil in the treatment of refractory uveitis

Oct. 28, 1999

AGN-192024 is better than latanoprost for lowering diurnal IOP

Oct. 28, 1999

Nonpeptide integrin antagonists from DuPont and use for inhibiting cell adhesion

Oct. 25, 1999

Alphagan safely and effectively lowers IOP in glaucoma patients

Oct. 25, 1999

News from AAO/PAAO joint meeting: droperidol may be indicated for glaucoma

Oct. 25, 1999

Development status update for antiglaucoma drug candidate

Oct. 22, 1999

Verteporfin prevents vision loss in AMD patients with predominantly classic CNV lesions

Oct. 19, 1999

Preclinical results indicate a new target for RP therapy: calcium channel blockade

Oct. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....